EUDA
REAL ESTATEEuda Health Holdings Ltd
Live · NASDAQ · May 9, Close
What's Moving EUDA Today?
No stock-specific AI insight has been generated for EUDA yet. Check back soon — insights are generated from recent news analysis.
52-Week Range
$13.17
Fundamentals
Trading
EUDA News
20 articles- EUDA Highlights Shenzhen Inno’s Approval Under Shenzhen Key Industry R&D Program for TCR-T Cell Therapy DevelopmentGlobeNewswire Inc.·Apr 28, 2026
- EUDA Health Holdings Limited Has Received Notice from Nasdaq that it has Failed to Maintain a Minimum Market Value of its Listed SecuritiesGlobeNewswire Inc.·Apr 27, 2026
- EUDA Announces Reverse Stock Split of its Ordinary SharesYahoo Finance·Mar 19, 2026
- EUDA Health price target lowered to $2.75 from $6 at GreenridgeYahoo Finance·Mar 10, 2026
- EUDA Health Holdings Limited Announces Repurchase and Cancellation of Streeterville WarrantYahoo Finance·Mar 4, 2026
- EUDA Health Announces Second Amendment to Streeterville Warrant AgreementYahoo Finance·Jan 15, 2026
- EUDA Enters into Convertible Loan Agreement with Shenzhen Inno, Further Expanding Stem Cell Therapy PlatformYahoo Finance·Jan 13, 2026
- EUDA Health Holdings Limited Announces Amendment to Streeterville Warrant AgreementYahoo Finance·Jan 7, 2026
- EUDA Launches Nationwide Stem Cell Extraction, Cryostorage and Clinical Delivery Platform in China with Shenzhen Inno Immune and Wuhan Kaien HospitalYahoo Finance·Dec 30, 2025
- EUDA Health to Launch EUDA Helixé 2.0 in January 2026Yahoo Finance·Dec 29, 2025
- Top Midday GainersYahoo Finance·Dec 23, 2025
- EUDA Accelerates Longevity Strategy with Launch of Comprehensive Stem Cell Therapy Platform and First Clinic in ShenzhenYahoo Finance·Dec 23, 2025
- Top Midday DeclinersYahoo Finance·Dec 22, 2025
- EUDA Health Holdings Limited Announces Execution of Securities Purchase AgreementYahoo Finance·Dec 5, 2025
- EUDA Subsidiary CK Health Plus Expands into India in Strategic Partnership with SafeRock IndiaYahoo Finance·Oct 23, 2025
- EUDA Subsidiary CK Health Plus Secures Malaysia Direct Selling License, Strengthening Its Longevity Business Across AsiaYahoo Finance·Oct 20, 2025
- EUDA Signs Letter of Intent to Potentially Acquire GO POSBYahoo Finance·Sep 10, 2025
- EUDA Strategically Expands into T-Cell Immunotherapy – Strengthening Its Stem Cell Therapy PortfolioYahoo Finance·Sep 4, 2025
- EUDA Signs Letter of Intent to Potentially Acquire Chemokine Pte LtdYahoo Finance·Aug 28, 2025
- EUDA Expands Wellness Product Portfolio With A Next-Generation Immune Health SupplementYahoo Finance·Aug 26, 2025
All 20 articles loaded
Price Data
52-Week Range
$13.17
Fundamentals
Trading
About Euda Health Holdings Ltd
EUDA Health Holdings Limited is a biopharmaceutical innovator dedicated to the discovery, development, and commercialization of transformative therapies addressing rare diseases and unmet medical needs. Leveraging cutting-edge technologies and a robust clinical pipeline, the company focuses on pivotal areas such as supportive care and immune modulation. With a strong commitment to research and development, EUDA is poised to advance healthcare innovation and enhance patient outcomes, while striving to broaden access to essential medical therapies through its promising clinical initiatives.